Aptevo Therapeutics Inc
General ticker "APVO" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $45.9M
Aptevo Therapeutics Inc does not follow the US Stock Market performance with the rate: -35.3%.
Estimated limits based on current volatility of 4.7%: low 4.13$, high 4.90$
Factors to consider:
- Current price 96.3% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [127.16$, 627.17$]
- 2024-12-30 to 2025-12-30 estimated range: [41.14$, 183.41$]
Financial Metrics affecting the APVO estimates:
- Negative: Non-GAAP EPS, $ of -70.93 <= 0.10
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: negative Net income
- Negative: Operating cash flow per share per price, % of -83.70 <= 2.35
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
- Negative: Industry earnings per price (median), % of -26.04 <= 1.31
- Negative: Inventory ratio change, % of 38.24 > 1.08
Short-term APVO quotes
Long-term APVO plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $12.29MM | $3.11MM | $0.00MM |
| Operating Expenses | $33.69MM | $31.75MM | $28.88MM |
| Operating Income | $-21.40MM | $-28.64MM | $-28.88MM |
| Non-Operating Income | $-8.01MM | $35.66MM | $10.23MM |
| R&D Expense | $18.99MM | $17.88MM | $17.11MM |
| Income(Loss) | $-29.41MM | $7.01MM | $-18.65MM |
| Other Income(Loss) | $0.95MM | $1.01MM | $1.24MM |
| Profit(Loss) | $-28.46MM | $8.03MM | $-17.41MM |
| Stockholders Equity | $1.22MM | $17.97MM | $12.22MM |
| Inventory | $3.08MM | $1.57MM | $0.00MM |
| Assets | $56.60MM | $34.22MM | $24.84MM |
| Operating Cash Flow | $-21.68MM | $-21.02MM | $-11.73MM |
| Capital expenditure | $0.71MM | $0.03MM | $0.00MM |
| Investing Cash Flow | $-0.71MM | $-0.03MM | $0.00MM |
| Financing Cash Flow | $26.16MM | $-2.62MM | $6.00MM |
| Earnings Per Share* | $-256.35 | $366.71 | $-62.62 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.